Factors Associated With Posttransplant Cardiac Outcomes

Recruiting Observational Study
Cardiovascular Diseases Liver Transplantation
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
200 (estimated)
Sponsor
Sun Yat-sen University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Cardiovascular disease has become the leading cause of death early after liver transplantation (LT). The aging LT population is accompanied with the increasing prevalence of cardiovascular risk factors such as hypertension, diabetes, and hyperlipidemia. Furthermore, cirrhosis has been known to cause alterations in the systemic haemodynamic system and cardiac muscle dysfunction, systolic and/or dia…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age \> 18 years, * End-stage cirrhosis patients who will receive liver transplantation, * Patients voluntarily take part in the study and write informed consent. Exclusion Criteria: * Decreased left ventricular systolic function (ejection fraction \<45%), * Significant uncor…
Contacts

Jia Liu, Dr

15920190962

395847953@qq.com

CONTACT

Jie Ren, Dr

13925155583

renj@mail.sysu.edu.cn

CONTACT